Pierre W. Wijermans
Pierre W. Wijermans publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments and Acute Lymphoblastic Leukemia research.
- World rank
- #543,191 of 7,710,434 ranked researchers
- Rank in Netherlands
- #13,287 of 107,149
- Works
- 111
- Citations
- 7.7k
- Citations per work
- 69.6
What does Pierre W. Wijermans research?
Pierre W. Wijermans's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6861.7%
- Medicine6861.7%
- Life Sciences2119.3%
- Everything else2119.0%
- 1Hematology38% of their works
- 2Molecular Biology16% of their works
- 3Oncology8% of their works
- 4Genetics8% of their works
- 5Public Health, Environmental and Occupational Health7% of their works
- 6Immunology3% of their works
Research topics
Which keywords describe Pierre W. Wijermans's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Minimal Residual Disease, Diagnosis Criteria, International Myeloma Working Group and Acute Lymphoblastic Leukemia.
- Histone Modification
- BCR-ABL
- BET Bromodomains
- Chemotherapy-Induced Peripheral Neuropathy
- Bone Marrow Niche
- Acute Lymphoblastic Leukemia
- Diagnosis Criteria
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Minimal Residual Disease
- International Myeloma Working Group
- Childhood Cancer
- Graft-versus-Host Disease
- Taxanes
- PROTACs
- DNA Methylation
- Imatinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors812 topics
- Hematopoietic Stem Cells762 topics
- AML601 topic
- Acute Myeloid Leukemia601 topic
- Minimal Residual Disease502 topics
- Diagnosis Criteria291 topic
- International Myeloma Working Group291 topic
- Acute Lymphoblastic Leukemia211 topic
- Childhood Cancer211 topic
- Bone Marrow Niche161 topic
- Graft-versus-Host Disease161 topic
- Chemotherapy-Induced Peripheral Neuropathy151 topic
- Taxanes151 topic
- BET Bromodomains141 topic
- PROTACs141 topic
- BCR-ABL131 topic
- DNA Methylation131 topic
- Histone Modification131 topic
- Imatinib131 topic
Where does Pierre W. Wijermans work?
Pierre W. Wijermans's main affiliation in the publication record is Haga Hospital, Netherlands.
How many publications and citations does Pierre W. Wijermans have?
OpenAlex counts 111 works and 7,731 citations for Pierre W. Wijermans, an h-index of 36, ranking #543,191 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pierre W. Wijermans. Posts are plain text and can be reported.